Study guide
13.1 Shock States, Sepsis & Systemic Inflammatory Response
USMLE Step 2 CK Study Guide Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Human Development & Well-Patient Care
1.1 Infant, Child & Adolescent Development & Growth 1.2 Adult Development, Aging & Geriatric Assessment 1.3 Preventive Health, Immunization & Well-Patient Screening
2 Chapter 2: Immune System & Immunologic Disorders
2.1 Primary & Secondary Immunodeficiencies 2.2 Hypersensitivity Reactions, Allergy & Anaphylaxis 2.3 Autoimmune & Rheumatologic Disease Principles
3 Chapter 3: Blood & Lymphoreticular System
3.1 Anemias: Microcytic, Normocytic & Macrocytic Etiologies 3.2 Bleeding Disorders, Coagulopathies & Platelet Pathology 3.3 Hematologic Malignancies & Lymphoproliferative Disorders
4 Chapter 4: Behavioral Health & Psychiatric Disorders
4.1 Mood Disorders: Major Depression & Bipolar Spectrum 4.2 Anxiety, Trauma-Related & Somatic Symptom Disorders 4.3 Psychotic Disorders & Schizophrenia Spectrum 4.4 Substance Use Disorders & Psychopharmacology
5 Chapter 5: Nervous System & Special Senses
5.1 Cerebrovascular Disease, Stroke & Transients 5.2 Seizures, Epilepsy & Altered Mental Status 5.3 Movement Disorders, Dementia & Peripheral Neuropathies 5.4 Special Senses: Ophthalmologic & Otolaryngologic Emergencies
6 Chapter 6: Musculoskeletal System & Dermatology
6.1 Fractures, Dislocations & Orthopedic Trauma 6.2 Inflammatory Arthropathies & Crystal-Induced Diseases 6.3 Inflammatory & Infectious Dermatoses 6.4 Cutaneous Malignancies & Blistering Disorders
7 Chapter 7: Cardiovascular System
7.1 Coronary Artery Disease & Acute Coronary Syndromes 7.2 Heart Failure, Cardiomyopathies & Valvular Disease 7.3 Cardiac Arrhythmias, Conduction Blocks & EKG Interpretation 7.4 Vascular Emergencies: Aortic Aneurysms & Peripheral Arterial Disease
8 Chapter 8: Respiratory System
8.1 Obstructive Airway Diseases: Asthma & COPD 8.2 Infectious Pneumonias & Pleural Effusions 8.3 Pulmonary Vascular Disease & Thromboembolism 8.4 Acute Respiratory Distress Syndrome & Interstitial Lung Diseases
9 Chapter 9: Gastrointestinal System
9.1 Esophageal, Gastric & Peptic Ulcer Disorders 9.2 Inflammatory Bowel Disease & Colorectal Neoplasms 9.3 Hepatic Disorders, Cirrhosis & Portal Hypertension 9.4 Biliary Tract Diseases & Pancreatitis
10 Chapter 10: Renal, Urinary & Reproductive Systems
10.1 Acute Kidney Injury & Chronic Kidney Disease 10.2 Glomerular & Tubulointerstitial Diseases 10.3 Nephrolithiasis, Urinary Tract Infections & Prostate Pathology 10.4 Fluid, Electrolyte & Acid-Base Disorders 10.5 Female Reproductive Disorders & Gynecology 10.6 Breast Pathology & Clinical Breast Disease
11 Chapter 11: Pregnancy, Childbirth & Puerperium
11.1 Normal Prenatal Care & Maternal-Fetal Physiology 11.2 Medical & Obstetric Complications of Pregnancy 11.3 Labor, Delivery & Postpartum Management
12 Chapter 12: Endocrine System
12.1 Diabetes Mellitus, Hypoglycemia & Metabolic Emergencies 12.2 Thyroid & Parathyroid Disorders 12.3 Adrenal & Pituitary Axis Pathology
13 Chapter 13: Multisystem Processes & Critical Care
13.1 Shock States, Sepsis & Systemic Inflammatory Response 13.2 Environmental Emergencies, Toxicology & Overdose 13.3 Infectious Disease Principles & Systemic Pathogens
14 Chapter 14: Biostatistics, Epidemiology & Literature Interpretation
14.1 Study Designs, Bias & Validity 14.2 Diagnostic Testing: Sensitivity, Specificity, PPV & NPV 14.3 Statistical Significance, Risk Measures & Evidence-Based Medicine
15 Chapter 15: Social Sciences, Ethics & Systems-Based Practice
15.1 Medical Ethics, Informed Consent & Patient Autonomy 15.2 Legal Issues, Confidentiality & Surrogate Decision Making 15.3 Patient Safety, Quality Improvement & Medical Error Analysis 15.4 Health Care Delivery Systems, Interprofessional Care & Transitions
13.1 Shock States, Sepsis & Systemic Inflammatory Response
Key Takeaways Explain This Topic AI
Septic shock is defined under Sepsis-3 criteria as persistent hypotension requiring vasopressors to maintain a mean arterial pressure (MAP) >= 65 mmHg AND a serum lactate level > 2.0 mmol/L despite adequate fluid resuscitation (30 mL/kg crystalloids within 3 hours).
Hypovolemic and cardiogenic shock exhibit elevated systemic vascular resistance (SVR > 1200 dynes·sec/cm⁵), whereas septic/distributive shock is uniquely characterized by low SVR (< 800 dynes·sec/cm⁵) and hyperdynamic cardiac output.
The qSOFA bedside screening tool requires 2 or more of the following criteria: respiratory rate >= 22 breaths/min, altered mental status (Glasgow Coma Scale < 15), and systolic blood pressure <= 100 mmHg.
First-line vasopressor therapy for septic shock is IV norepinephrine, targeting a MAP >= 65 mmHg; vasopressin (0.03 units/min) is added as a second-line agent for refractory hypotension.
Hydrocortisone 200 mg/day IV is indicated in septic shock only when hemodynamic stability is unachievable despite fluid resuscitation and escalating vasopressor therapy.
Last updated: July 2026
13.1 Shock States, Sepsis & Systemic Inflammatory Response
Shock is defined as a state of systemic cellular dysoxia resulting from an imbalance between oxygen delivery ( D O 2 DO_2 D O 2 ) and oxygen demand ( V O 2 VO_2 V O 2 ). When tissue perfusion falls below critical levels, cells switch to anaerobic metabolism, leading to cellular lactic acidosis, organ failure, and death if uncorrected. For USMLE Step 2 CK, mastering shock requires distinguishing the distinct hemodynamic profiles of the four major shock categories and applying time-sensitive clinical bundles for sepsis and septic shock.
Hemodynamic Classification of Shock States
Shock is broadly categorized into four major etiologic classes based on primary intravascular and cardiac dynamics: hypovolemic , cardiogenic , obstructive , and distributive .
1. Hypovolemic Shock
Hypovolemic shock results from a critical loss of intravascular volume, either due to acute hemorrhage (trauma, GI bleeding, ruptured aneurysm) or non-hemorrhagic fluid loss (severe vomiting, diarrhea, burns, third-spacing).
Primary disturbance: Decreased preload, reflected by a reduced Pulmonary Capillary Wedge Pressure (PCWP) or Central Venous Pressure (CVP) .
Compensatory response: Decreased stroke volume causes a drop in Cardiac Output (CO) / Cardiac Index (CI) , triggering compensatory sympathetic activation that increases Systemic Vascular Resistance (SVR) via vasoconstriction to maintain blood pressure.
Mixed Venous Oxygen Saturation ( S v O 2 SvO_2 S v O 2 ): Decreased ( < 65 % < 65\% < 65% ) due to increased peripheral oxygen extraction from sluggish tissue perfusion.
2. Cardiogenic Shock
Cardiogenic shock stems from primary cardiac pump failure resulting in inadequate tissue perfusion despite adequate intravascular volume. Common causes include acute myocardial infarction (occupying > 40 % > 40\% > 40% of left ventricular mass), acute mitral regurgitation secondary to papillary muscle rupture, acute ventricular septal rupture, and end-stage dilated cardiomyopathy.
Primary disturbance: Severe impairment of myocardial contractility leading to decreased CO/CI ( < 2.2 L/min/m 2 < 2.2 \text{ L/min/m}^2 < 2.2 L/min/m 2 ).
Hemodynamic findings: Elevated PCWP ( > 18 mmHg > 18 \text{ mmHg} > 18 mmHg ) due to left ventricular end-diastolic fluid overload and backing up of pressure into the pulmonary vasculature, alongside reflex vasoconstriction causing high SVR ( > 1200 dynes ⋅ sec/cm 5 > 1200 \text{ dynes}\cdot\text{sec/cm}^5 > 1200 dynes ⋅ sec/cm 5 ).
S v O 2 SvO_2 S v O 2 : Markedly decreased ( < 55 % < 55\% < 55% ) secondary to low tissue perfusion and maximal tissue oxygen extraction.
3. Obstructive Shock
Obstructive shock occurs when physical obstruction to cardiac inflow or outflow impairs ventricular filling or stroke volume. Causes include tension pneumothorax, cardiac tamponade, massive pulmonary embolism (PE), and restrictive pericarditis.
Hemodynamic profile: Characterized by low CO/CI and elevated compensatory SVR .
Preload parameters: Differ by etiology:
Cardiac Tamponade: Equalization of end-diastolic pressures across all cardiac chambers (CVP = Right Ventricular End-Diastolic Pressure = PCWP) with classic Beck triad (hypotension, jugular venous distension, muffled heart sounds) and pulsus paradoxus ( > 10 mmHg > 10 \text{ mmHg} > 10 mmHg drop in SBP during inspiration).
Massive PE: Markedly elevated CVP with normal or low PCWP (right ventricular failure without left atrial overload).
Tension Pneumothorax: Elevated CVP with decreased breath sounds and tracheal deviation away from the affected side.
4. Distributive Shock
Distributive shock is caused by profound systemic vasodilation and increased capillary permeability, leading to functional hypovolemia despite normal or elevated total intravascular volume. Causes include sepsis (most common), anaphylaxis , and neurogenic shock (spinal cord injury above T6 causing loss of sympathetic tone).
Primary disturbance: Severe fall in SVR ( < 800 dynes ⋅ sec/cm 5 < 800 \text{ dynes}\cdot\text{sec/cm}^5 < 800 dynes ⋅ sec/cm 5 ).
Compensatory response: To maintain perfusion, cardiac output increases, creating a hyperdynamic state with elevated CO/CI ( > 4.0 L/min/m 2 > 4.0 \text{ L/min/m}^2 > 4.0 L/min/m 2 ) and warm, flushed extremities.
PCWP/CVP: Normal or low due to venous pooling and capillary leak.
S v O 2 SvO_2 S v O 2 : Uniquely elevated ( > 70 % > 70\% > 70% ) in early septic shock due to microvascular shunting and cellular inability to utilize oxygen (cytopathic hypoxia).
Hemodynamic Parameters Comparison
The following table summarizes the diagnostic hemodynamic profiles measured via Pulmonary Artery Catheter (Swan-Ganz) placement on USMLE Step 2 CK:
Shock Type Preload (PCWP / CVP) Cardiac Output (CO / CI) Afterload (SVR) Mixed Venous S v O 2 SvO_2 S v O 2 Clinical Features
Hypovolemic Decreased ( ↓ \downarrow ↓ ) Decreased ( ↓ \downarrow ↓ ) Increased ( ↑ \uparrow ↑ ) Decreased ( ↓ \downarrow ↓ ) Cold, clammy skin, flat neck veins, tachycardia
Cardiogenic Increased ( ↑ \uparrow ↑ ) Decreased ( ↓ ↓ \downarrow\downarrow ↓↓ ) Increased ( ↑ \uparrow ↑ ) Decreased ( ↓ ↓ \downarrow\downarrow ↓↓ ) S3 gallop, rales, JVD, cool extremities
Obstructive Variable ( ↑ / ↓ \uparrow/\downarrow ↑ / ↓ ) Decreased ( ↓ \downarrow ↓ ) Increased ( ↑ \uparrow ↑ ) Decreased ( ↓ \downarrow ↓ ) Tamponade: equalization of pressures; PE: high CVP, low PCWP
Septic (Early) Low / Normal ( ↓ / ↔ \downarrow/\leftrightarrow ↓ / ↔ ) Increased ( ↑ ↑ \uparrow\uparrow ↑↑ ) Decreased ( ↓ ↓ \downarrow\downarrow ↓↓ ) Increased ( ↑ \uparrow ↑ ) Warm extremities, bounding pulses, wide pulse pressure
Neurogenic Decreased ( ↓ \downarrow ↓ ) Decreased ( ↓ \downarrow ↓ ) Decreased ( ↓ ↓ \downarrow\downarrow ↓↓ ) Decreased ( ↓ \downarrow ↓ ) Bradycardia (loss of cardiac sympathetics), warm skin
Sepsis-3 Definitions and Pathophysiology
The Sepsis-3 consensus guidelines redefined sepsis and septic shock, discarding the historical Systemic Inflammatory Response Syndrome (SIRS) criteria for official sepsis diagnosis due to lack of specificity.
Sepsis vs. Septic Shock
Sepsis: Defined as a life-threatening organ dysfunction caused by a dysregulated host response to infection. Organ dysfunction is quantified as an acute change in total Sequential Organ Failure Assessment (SOFA) score of ≥ 2 \ge 2 ≥ 2 points attributable to the infection.
Septic Shock: A subset of sepsis in which particularly profound circulatory, cellular, and metabolic abnormalities increase mortality. Diagnosed when patients satisfy sepsis criteria AND present with:
Persistent hypotension requiring vasopressors to maintain a Mean Arterial Pressure (MAP) ≥ 65 mmHg \ge 65 \text{ mmHg} ≥ 65 mmHg , AND
Serum lactate > 2.0 mmol/L > 2.0 \text{ mmol/L} > 2.0 mmol/L ( > 18 mg/dL > 18 \text{ mg/dL} > 18 mg/dL ) despite adequate fluid resuscitation ( 30 mL/kg 30 \text{ mL/kg} 30 mL/kg crystalloid).
Bedside Screening: qSOFA and SIRS
Outside the ICU, the quick SOFA (qSOFA) tool rapidly identifies patients at risk for deterioration. A score ≥ 2 \ge 2 ≥ 2 prompts immediate investigation for sepsis: qSOFA Criteria (1 point each): \text{qSOFA Criteria (1 point each):} qSOFA Criteria (1 point each):
- Respiratory rate ≥ 22 breaths/min \ge 22 \text{ breaths/min} ≥ 22 breaths/min
- Altered mental status (Glasgow Coma Scale score < 15 < 15 < 15 )
- Systolic blood pressure ≤ 100 mmHg \le 100 \text{ mmHg} ≤ 100 mmHg
(Note: Historical SIRS criteria required ≥ 2 \ge 2 ≥ 2 of: Temp > 38 ∘ C >38^\circ\text{C} > 3 8 ∘ C or < 36 ∘ C <36^\circ\text{C} < 3 6 ∘ C ; HR > 90 >90 > 90 ; RR > 20 >20 > 20 or PaCO 2 < 32 mmHg \text{PaCO}_2 <32 \text{ mmHg} PaCO 2 < 32 mmHg ; WBC > 12 , 000 >12,000 > 12 , 000 , < 4 , 000 <4,000 < 4 , 000 , or > 10 % >10\% > 10% bands).
Diagnostic and Resuscitation Bundles
Management of septic shock is time-critical. The Surviving Sepsis Campaign emphasizes the 1-Hour Resuscitation Bundle : +-----------------------------------------------------------------------------------+
- | 1-HOUR SEPSIS BUNDLE ACTIONS |
- +-----------------------------------------------------------------------------------+
- | 1. Measure serum lactate level (remeasure if initial lactate > 2 mmol/L). |
- | 2. Obtain blood cultures prior to administration of antibiotics. |
- | 3. Administer empiric broad-spectrum IV antibiotics (e.g., Cefepime + Vancomycin). |
- | 4. Rapidly infuse 30 mL/kg IV crystalloid for hypotension or lactate >= 4 mmol/L. |
- | 5. Apply vasopressors (Norepinephrine) if MAP < 65 mmHg during/after fluid resus.|
- +-----------------------------------------------------------------------------------+
- Vasopressor and Inotropic Management
First-line Vasopressor: Norepinephrine (potent α 1 > β 1 \alpha_1 > \beta_1 α 1 > β 1 agonist) is the initial drug of choice to restore vascular tone without excessive tachycardia. Target MAP is ≥ 65 mmHg \ge 65 \text{ mmHg} ≥ 65 mmHg .
Second-line Vasopressor: Vasopressin ( 0.03 units/min 0.03 \text{ units/min} 0.03 units/min ) is added to norepinephrine to raise MAP or reduce norepinephrine dosage.
Inotrope: Dobutamine ( β 1 > β 2 \beta_1 > \beta_2 β 1 > β 2 agonist) is added if myocardial dysfunction persists (elevated PCWP with low CO) despite adequate volume and MAP.
Corticosteroids: IV Hydrocortisone ( 200 mg/day 200 \text{ mg/day} 200 mg/day ) is indicated ONLY in refractory septic shock where fluid resuscitation and vasopressors fail to restore hemodynamic stability.